INTRODUCTION
============

Mouse embryonic stem cells (mESCs) are derived from the inner cell mass (ICM) of blastocysts during development. Because they can differentiate into any type of cell, mESCs have been used to study the molecular mechanisms in early mammalian organogenesis [@B010]. In the presence of leukemia inhibitory factor (LIF), mESCs can be maintained indefinitely in a self-renewing state that closely resembles the pluripotent cells of the ICM. LIF signaling is initiated through the dimerization of the cytokine receptors, the LIF receptor (LIFR) and glycoprotein130, after their engagement by cytokine [@B031]. This complex activates the Janus kinase (JAK) and the signal transducer and activator of transcription 3 (STAT3) signaling pathways, resulting in the subsequent dimerization, nuclear translocation, and target gene activation of STAT3, which are crucial for the maintenance of the self-renewal of mESCs [@B009]; [@B038]. STAT3 has been reported to be not only an important substrate for activated JAKs, but also a crucial regulator of the LIF-induced self-renewal of mESCs [@B029]. Therefore, when LIF is removed or differentiation signals are added, mESCs begin to differentiate into many types of cells, including endothelial cells [@B026], adipocytes [@B006], neurons [@B034], and smooth muscle cells [@B007]; [@B039].

During normal organogenesis, the early embryo undergoes a transient, low pO~2~ concentration (\~5% O~2~, or hypoxia) until vascularization begins, since which may cause an increase in the oxygen requirements [@B011]; [@B021]; [@B033]; [@B037]. Hypoxia is detectable in many regions during normal embryo development [@B025] including reproductive tract [@B028], the microvasculature [@B014], and the ocular vitreous [@B036], even after well-developed vascularization. and even after a well-developed vascularization [@B033]. Hypoxia inducible factor-1α (HIF-1α) is an important transcription factor that acts under low oxygen conditions, and the expression and activity of HIF-1α are regulated by oxygen concentration [@B035]; [@B023]; [@B032]. The stability of HIF-1α is regulated by post-translational modifications, such as hydroxylation [@B004], sumoylation [@B003], acetylation [@B016], and phosphorylation. These modifications are mediated by the interaction of HIF-1α with several proteins, including prolyl hydroxylases (PHDs), histone deacetylases (HDACs), ARD-1, pVHL, PKC-δ and p300/CBP [@B016]; [@B018]. In particular, class I HDACs (HDAC1 and HDAC3) enhance HIF-1α stability and transactivation in hypoxic conditions and are considered positive regulators of HIF-1α stability [@B019].

Previously, we demonstrated that HIF-1α may act as a negative regulator of the LIFR-STAT3 pathway and thus be important for the hypoxia-induced early differentiation of mESCs [@B015]. Furthermore, we reported that PKC-δ inhibitors block the early differentiation of mESCs under hypoxia via the destabilization of HIF-1α [@B022]. HDACIs effectively inhibited HIF-1α stability in cancer cells; however, the relevance of the HDACIs as regulators of self-renewal activity in hypoxia-induced differentiation in mESCs is largely unknown. Threfore, we examined the role of HDACIs in hypoxia-induced differentiation using feeder-free mESCs. Our data show that HDACIs destabilized HIF-1α protein and blocked the downregulation of LIFR-STAT3 signaling during hypoxia-induced differentiation of mESCs. Notably, valproic acid (VPA) robustly inhibited the downregulation of the LIFRSTAT3 pathway mediated by HIF1α, which in turn sustained the self-renewal of mESCs under hypoxia. Therefore, our results suggest an inhibitory role for VPA in the hypoxia-induced early differentiation of mESCs.

MATERIALS AND METHODS
=====================

Cell culture
------------

mESC lines, CCE cultured under feeder-free conditions were maintained in knockout-DMEM (Invitrogen, Grand Island, NY) containing 15% defined serum replacement (Knockout SR^TM^; Invitrogen, Grand Island, NY), 1 mM glutamine, 50 U/ml penicillin, 50 μg/ml streptomycin, 1% non-essential amino acids, 0.1 mM β-mercaptoethanol, and 1,000 U/ml LIF (ESGRO; Chemicon, Temecula, CA). For hypoxic conditions, CCE cells were incubated at 1% O~2~ level with 5% CO~2~ balanced with N~2~ in a hypoxic chamber (Forma Scientific, Marietta, OH, USA) with an interior temperature of 37℃.

Reagents
--------

Valproic acid, trichostatin A and sodium butyrate were purchased from Sigma-Aldrich (St. Louis, MO, USA). Apicidin was purchased from Calbiochem (Darmstadt, Germany).

RT-PCR analysis and primers
---------------------------

Total RNA from cells was isolated using Trizol reagent (Invitrogen, Grand Island, NY) according to the manufacturer's instructions and quantified by spectrophotometer (NanoDrop, Nyxor Biotech). First-stranded cDNA was synthesized with 5 ug of each DNA-free total RNA and oligo-(dT)~16~ primer by *Moloney* murine leukemia virus reverse transcriptase (Promega, Madison, WI, USA). One microlitre of cDNA was amplified by PCR using 1.25U of ExTaq DNA polymerase kit (Takara, Madison, WI). The primers used had the following sequences: fgf4 forward, 5'-TACTGCAACGTGGGCATCGGA-3'; reverse, 5'-GTGGGTTACCTTCATGGTAGG-3'; rex1 forward, 5'-CGT-GTAACATACACCATCCG-3'; reverse, 5'-GAAATCCTCTTCCAGAAT-GG-3'; fgf5 forward, 5'-ATGAGCCTGTCCTTGCTC-3'; reverse, 5'-GTCTGTACTTCACTGGGC-3'; STAT5a for ward, 5'-GCTGTATCCG-TCACATTCTG-3'; reverse, 5'-CCACTGGATCAGCTCGTCGT-3'; gapdh forward, 5'-AACGGGAAGCCCATCACC-3'; reverse, 5'-CAGCCTTGGCAGCACCAG-3'.The PCR products were separated on 1.2-1.5% agarose gels and visualized by ethidium bromide staining under a UV transilluminator.

Western blot analysis
---------------------

Cells were harvested and the pellets were immediately frozen in liquid Nitrogen. After thawing, the cell pellet lysed in lysis buffer (20 mM Tris-HCl (pH 7.5); 150 mM NaCl; 1 mM Na2EDTA; 1 mM EGTA; 1% Triton; 2.5 mM sodium pyrophosphate;1 mM beta-glycerophosphate; 1 mM Na~3~VO~4~; 1 μg/ml leupeptin) followed by centrifugation for 30 min at 15,000 rpm and protein concentration was determined by the BCA assay (Sigma, St. Louis, MO) and protein extracts were resolved in SDS-PAGE gels and transferred onto nitrocellulose membrane (Amersham Pharmacia Biotech, Piscataway, NJ).The protein-bearing membrane was blocked with 5% skim milk and probed with specific primary antibodies to HIF-1α (Cayman Chemical), LIFR (Santa Cruz Biotechnology, Santa Cruz, CA), tyr-705-phosphorylated Stat3, lys-9-acetylated histone 3 (Cell Signaling Technology, Beverly, MA) and α-tubulin (InnoGenex, San Ramon, CA), followed by incubation with secondary HRP-conjugated antibodies to mouse or rabbit IgG (Pierce, Rockford, IL). Antibody detection was performed by standard procedures using ECL Plus reagent (Amersham Pharmacia Biotech, Piscataway, NJ).

Immunofluorescence
------------------

Cells were fixated with 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS; pH 7.4) for 15 min and directly permeabilized with 0.1% Triton X-100 in PBS for 20 min. Then, cells were blocked with 5% BSA in PBS-T for 1 h at room temperature (RT). Next, anti-LIFR antibody (Santa Cruz Biotechnology, Santa Cruz, CA) was applied overnight at 4℃ and washed three times with PBS-T. Then, cells were incubated with secondary Alexa546-conjugated IgG (Molecular Probes, Inc.). Nuclear counterstaining was performed using DAPI (Molecular Probes, Inc.). Fluorescence staining was evaluated using a fluorescence microscope (Carl Zeiss, Germany).

Alkaline Phosphatase (AP) assay
-------------------------------

The cells were fixed with 4% paraformaldehyde for 2 minutes at room temperature. Staining for alkaline phosphatase (AP) was performed using a diagnostic kit (Sigma) following protocols provided by the manufacturer.

Statistical analysis
--------------------

The data are expressed as mean ± S.E.M., and were analyzed using analysis of variance or Student's t test as appropriate. *p*\<0.05 was considered statistically significant.

RESULTS
=======

HDAC inhibitors downregulate the protein expression of HIF-1α in mESCs under hypoxia
------------------------------------------------------------------------------------

HDACs stabilize the HIF-1α protein and their inhibitors de-stabilize HIF-1α under hypoxic conditions in human cancer cells [@B019]; [@B024]. However, because the effect of HDACs and their specific inhibitors varies depending on the dose, the duration of treatment, and the types of cells treated, we examined the role of several HDAC inhibitors such as sodium butyrate (SB), trichostatin A (TSA), apicidin (AP), and valproic acid (VPA) on the hypoxia-induced differentiation of CCE mESCs. Thus, we cultured mESCs with the indicated inhibitors under both normoxic (20% O~2~) and hypoxic (1% O~2~) culture conditions in the presence of LIF. We evaluated the effect of these inhibitors on HIF-1α expression by Western blot analysis. HIF-1α protein levels were higher

![HDAC inhibitors (HDACIs) decreased HIF-1α protein levels under hypoxic conditions in mouse embryonic stem cells (mESCs). (A, B) CCE cells were treated with HDAC inhibitors, 1 mM sodium butyrate (SB) 5 ng/ml trichostatin A (TSA) 100 nM apicidin (AP) and 1 mM valproic acid (VPA), and were then immediately exposed to hypoxia for 24 h. (A) HIF-1α and α-tubulin were examined using Western blot analysis. The graph represents the mean values ± SD (n=3). \*p\<0.01; ^\#^p\<0.01. (B) The expression level of HIF-1α mRNA was examined using RT-PCR. GAPDH and α-tubulin were used as internal controls. N: normoxia H: hypoxia; Results are representative of three independent experiments.](ooomb4-20-280-g001){#F001}

under hypoxia than under normoxia and markedly decreased after treatment with the HDAC inhibitors, including SB, TSA, AP, and VPA ([Fig. 1](#F001){ref-type="fig"}A). Notably, VPA was more effective than the other inhibitors in downregulating HIF-1α. In contrast, HIF-1α mRNA expression did not change in CCEs treated with inhibitors under hypoxia ([Fig. 1](#F001){ref-type="fig"}B). These results suggest that HDAC inhibitors destabilize HIF-1α protein levels under hypoxia in mESCs.

HDAC inhibitors block the down-regulation of the LIFR-STAT3 pathway under hypoxia
---------------------------------------------------------------------------------

Previously, we reported that HIF-1α binds to reverse HREs in the LIFR promoter, leading to the downregulation of LIFR-STAT3 signaling in mESCs under hypoxia [@B015]. To examine the effect of HDAC inhibitors on LIFR-STAT3 signaling, we cultivated mESCs in the presence of LIF with four kinds of HDAC inhibitors, SB, TSA, AP, and VPA under hypoxic conditions. Expression of LIFR and phosphorylation of STAT3 decreased under hypoxia, whereas treatment with HDAC inhibitors effectively blocked the hypoxia-induced reduction of LIFR and phosphorylated-STAT3 ([Fig. 2](#F002){ref-type="fig"}). Moreover, VPA markedly increased the phosphorylation of STAT3 under hypoxia to levels comparable to that of the control (normoxia). Therefore, these results suggest that HDAC inhibitors may maintain LIFR-STAT3 signaling under hypoxia.

![HDAC inhibitors blocked the down-regulation of LIFR-STAT3 pathway under hypoxia in mESCs. CCE cells were treated with HDAC inhibitors 1 mM sodium butyrate (SB), 5 ng/ml trichostatin A (TSA), 100 nM apicidin (AP), and 1 mM valproic acid (VPA), and were then immediately exposed to hypoxia for 24 h. Western blot analysis of LIF receptor (LIFR), phosphorylated-STAT3 (p-STAT3, at tyrosine 705 residue) and α-tubulin in CCE cells treated with HDAC inhibitors. α-Tubulin was used as internal control. Graph represents mean values ± S.D. (n = 3). \*p\<0.05; \*\*p\<0.01; ^\#^p\<0.05; ^\#\#^p\<0.01.](ooomb4-20-280-g002){#F002}

Valproic acid (VPA) suppresses the downregulation of the LIFR-STAT3 pathway under hypoxia in mESCs in a dose-dependent manner
-----------------------------------------------------------------------------------------------------------------------------

VPA was more effective than other HDAC inhibitors in the attenuation of the HIF-1α and LIFR-STAT3 pathways ([Fig. 1](#F001){ref-type="fig"}A and [Fig. 2](#F002){ref-type="fig"}); in addition, VPA improves the reprogramming efficiency

![Valproic acid (VPA), a HDAC inhibitor, suppressed the downregulation of the LIFR-STAT3 pathway under hypoxia in mouse embryonic stem cells in a dose-dependent manner. (A) CCE cells were treated with 0.1, 1.0, and 10.0 mM valproic acid (VPA), and were then exposed immediately to hypoxia for 24 h. Western blot analysis of LIF receptor (LIFR), phosphorylated-STAT3 (p-STAT3, at tyrosine 705 residue), lysine-9-acetylated histone 3 (Ac-H3), and α-tubulin in CCE cells treated with VPA. α-Tubulin was used as internal control. Graph represents mean values ± S.D. (n = 3). \*p\<0.05; \*\*p\<0.01; ^\#^p\<0.05; ^\#\#^p\<0.01. (B) Immunofluorescent staining with LIFR (red) of cells treated for 24h with 1 mM valproic acid (VPA) and grown under normoxic conditions (N) hypoxic conditions (H) in the presence of LIF. Nuclei are stained with DAPI (blue). Scale bar is 50 ㎛.](ooomb4-20-280-g003){#F003}

of somatic cells into induced pluripotent stem cells in both mouse and human cells [@B012]; [@B013]. Therefore, the role of VPA as a negative regulator of stem cell differentiation under hypoxia warrants further investigation. We treated mESCs cultivated in the presence of LIF under hypoxic conditions with 0.1, 1.0, and 10.0 mM of VPA. Expression of LIFR and phosphorylation of STAT3 was downregulated under hypoxia, whereas treatment with VPA effectively blocked the hypoxia-induced reduction of LIFR and phosphorylated-STAT3 in a dose-dependent manner ([Fig. 3](#F003){ref-type="fig"}A). We further confirmed the effect of VPA on the hypoxia-induced differentiation of mESCs using immunofluorescence with LIFR. Undifferentiated mESCs cultured under normoxia showed abundant expression of LIFR in the plasma membrane, whereas the expression of LIFR decreased under hypoxia ([Fig. 3](#F003){ref-type="fig"}B). Taken together, these results demonstrate that VPA inhibits the downregulation of the LIFR-STAT3 pathway under hypoxia in mESCs in a dose-dependent manner.

The acetylation levels of Histone H3 at lysine 9 (H3K9ac) are higher in mouse and human ESCs than in differentiated cells [@B002]; [@B008] and globally decrease during the endoderm-like differentiation of human ESCs [@B020]. Thus, we examined the changes in H3K9ac during VPA treatment under hypoxia. The levels of H3K9ac were downregulated under hypoxia, whereas treatment with VPA effectively blocked the hypoxia-induced reduction of H3K9ac in a dose-dependent manner ([Fig. 3](#F003){ref-type="fig"}A). These results suggest that VPA may maintain the acetylated state of histone H3, which is important for the self-renewal of mESCs under hypoxia.

Valproic acid (VPA) maintains the self-renewal and blocks the early differentiation of mESCs under hypoxia
----------------------------------------------------------------------------------------------------------

Based on the effect of VPA on LIFR-STAT3, RT-PCR was conducted to assess the state of mESCs. Rex1 and Fgf4 are representative markers for mESC stemness and self-renewal activity, whereas Fgf5 and Stat5a are markers for early differentiation [@B022]. Expression levels of Rex1 and Fgf4 decreased under hypoxia; treatment with VPA blocked the suppression of the Rex1 and Fgf4 in a dose-dependent manner ([Fig. 4](#F004){ref-type="fig"}A). In contrast, the expression levels of Fgf5 and Stat5a increased under hypoxia, and treatment with VPA blocked this increase ([Fig. 4](#F004){ref-type="fig"}A). These results suggest that VPA maintains the self-renewal state and blocks the early differentiation of mESCs under hypoxia.

We confirmed the state of mESCs with alkaline phosphatase (AP), a widely used stem cell marker [@B023]. When fixed mESCs are stained with AP, undifferentiated cells appear brown or purple in compact colonies, and differentiated cells are colorless. AP staining showed many purple colonies under normoxic conditions and many colorless cells under hypoxia ([Fig. 4](#F004){ref-type="fig"}B). However, AP-positive violet colonies markedly increased after treatment with VPA. As shown in [Fig. 4](#F004){ref-type="fig"}B, when the data are normalized to the normoxic conditions, hypoxia decreased the AP activity (\~25% compared with normoxia) ([Fig. 4](#F004){ref-type="fig"}B). But, undifferentiated colonies distinctly increased after treatment with VPA (about twofold compared with hypoxia). Thus, these results suggest that the inhibition of HIF-1α by VPA may maintain AP activity under hypoxia.

Taken together, these results suggest that VPA may sustain the stemness of mESCs and suppress the early differentiation

![Valproic acid (VPA), a HDAC inhibitor maintained the self-renewal and blocked the early differentiation of mESCs under hypoxia. (A, B) CCE cells were grown under normoxic conditions (N), hypoxic conditions (H) and hypoxia and were treated for 24 h with0.1, 1.0, and 10.0 mM valproic acid (VPA) in the presence of LIF. (A) The fate of mESCs was determined using self-renewal markers (rex1 and fgf4) and early differentiation markers (fgf5 and stat5a) expression levels using RT-PCR. Gapdh was used as an internalcontrol. Results are representative of three independent experiments.(B) Undifferentiated mESCs were identified by alkalinephosphatase (AP) activity assay staining (blue). Undifferentiatedcolonies (%) were quantified by calculating the AP-positive colonies as described in 'Materials and Methods'. Graph representsmean values ± S.D. (n = 4). \*p\<0.01.](ooomb4-20-280-g004){#F004}

of mESCs under hypoxia.

DISCUSSION
==========

The hypoxia-inducible factor-1α (HIF-1α) is an important transcription factor for many cellular responses to hypoxia that include angiogenesis, glycolysis, resistance to apoptosis, and differentiation [@B027]. Therefore, a specific regulator of HIF-1α may be a useful agent to study many aspects of cellular regulation, particularly in cell-fate decisions [@B037]. Here, we describe the negative role of VPA (a HDAC inhibitor) in hypoxia-induced differentiation of mESCs via the downregulation of HIF-1α.

Among the various classes of HDAC enzymes, class I and II HDACs deacetylate and thus stabilize HIF-1α protein under hypoxia [@B019]. In addition, HDAC inhibitors suppress the deacetylating activity of HDAC and induce acetylation of HIF-1α, which leads to the destabilization of HIF-1α[@B019]. More specifically, sodium butyrate (SB) is an inhibitor of class I and class IIa HDACs; apicidin and valproic acid are specific inhibitors of class I HDACs; trichostatin A is potent pan-HDAC inhibitors [@B019]. In the present study, treatment of mESCs with HDAC inhibitors led to a marked reduction of HIF-1α protein levels under hypoxia ([Fig. 1](#F001){ref-type="fig"}A). Therefore, the inhibitory effect of HDACs on the downreg-ulation of HIF-1α in mESCs may be mediated by the inhibition of class I and/or II HDACs.

The decrease in early differentiation markers expression was most dramatic in cells treated with VPA. A possible explanation for the inhibitory role of VPA in mESCs is based on the notion that HDAC inhibitors may suppress the hypoxia-induced differentiation of mESCs by promoting cellular responsiveness to LIF. Previous reports showed that FR901228, an inhibitor of histone deacetylases, increases the sensitivity to IL-6-type cytokines in different cell types, including normal fibroblasts, epithelial cells, macrophages, splenocytes, and various tumor cell lines [@B005]. This report is consistent with our data showing the effect of HDAC inhibitors in maintaining and enhancing the LIFR-STAT3 pathway under hypoxia ([Fig. 2](#F002){ref-type="fig"}, [3](#F003){ref-type="fig"}), which suggests a suppressive role for HDAC inhibitors. However, the opposite role for HDAC inhibitors in differentiation has also been reported. For example, TSA promotes myocardial differentiation when added to 7-day-old embryonic bodies [@B017] and enhances neuronal differentiation when added to embryonic neural stem cells [@B001] via transcriptional activation of restricted and specific genes [@B030]. In these experiments, the inhibitor dose and the duration of treatment were different from those of our experiments; note that the effect of HDACis varies depending on the dose, the duration of the treatment, and the differentiation state of the treated cells. More importantly, in these experiments, the differentiation of mESCs was induced in the absence of LIF and thus no IL-6-type cytokines exist whose sensitivities are increased by HDACis. In contrast, we cultured mESCs under hypoxia in the presence of LIF. Therefore, our results suggest that HDACis may increase the responsiveness to LIF under hypoxia, which leads to the suppression of the differentiation of ESCs.

In summary, our data indicate that VPA had a negative effect on HIF-1α stability in mESCs under hypoxia. Furthermore, VPA prevented the attenuation of the LIFR-STAT3 pathway by partially increasing the responsiveness to LIF, which led to the inhibition of differentiation under hypoxia. Taken together, these results suggest that VPA suppresses the hypoxia-induced differentiation of mESCs and may be important for understanding the molecular mechanisms underlying the physiological events during mammalian embryogenesis.
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